Prolacta’s Human Milk-Based Nutrition Has Touched the Lives of 100,000 Premature and Critically Ill Infants Globally

Milestone Celebrated During Prematurity Awareness Month DUARTE, Calif., Nov. 17, 2023 /PRNewswire/ — Prolacta Bioscience, the world’s leading hospital provider of 100% human milk-based nutritional products for critically ill, premature infants, proudly commemorates Prematurity Awareness…

Click here to view original post